Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Assembly committee amends, releases bill to eliminate cost sharing for guideline prostate screening
Summary
The committee amended and released AB1142 to expand coverage of guideline-recommended prostate screening and to prohibit cost sharing. Testimony included business concerns about aggregate mandate costs, survivor testimony about hereditary prostate cancer and American Cancer Society data showing small fiscal impacts in other states.
The Financial Institutions and Insurance Committee amended and released Assembly Bill 1142, which would require health carriers to provide prostate cancer screening coverage without cost sharing for guideline-recommended tests and change the bill’s effective date for individual market policies to Jan. 1, 2027.
Althea Ford, vice president of government affairs for the New Jersey Business & Industry Association, said she supports the screening objective but emphasized process concerns: BIA worried about…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
